Since 1996 WHN is the second oldest medical website on the net, second only to the American Medical Association, servicing over 35,000 physicians and scientists worldwide.

Non-Profit Trusted Source of Non-Commercial Health Information

WHN Forum background globe
Forums
Infections
Infectious Diseases
Ansun Biopharma Ann...
 
Notifications
Clear all

Ansun Biopharma Announces Independent Data Monitoring Committee Recommendation ...

 
Infectious Diseases
Last Post by Anonymous 2 weeks ago
1 Posts
1 Users
0 Reactions
23 Views
Solved
RSS
 Dr. Patterson
(@Dr. Patterson)
Joined: 2 months ago
Posts: 18
Topic starter 02/06/2026 4:01 am  

... respiratory infections. The Company is completing a Phase 3 clinical trial of its lead product candidate, DAS181, a host-directed antiviral. By ...

https://www.prnewswire.com/news-releases/ansun-biopharma-announces-independent-data-monitoring-committee-recommendation-supporting-continued-phase-3-development-of-das181-in-immunocompromised-patients-with-parainfluenza-infection-302787233.html



   
Quote
Topic Tags
infections antiviral ansun biopharma biopharma announces announces independent

Leave a reply

Author Name

Author Email

Title *

Maximum allowed file size is 50MB

 
Preview 0 Revisions Saved
Forum Jump:
  Previous Topic
Next Topic  
Related Topics
Topic Tags:  infections (322) , antiviral (17) , ansun biopharma (1) , biopharma announces (1) , announces independent (1) ,